Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Gilead Sciences EPS - Earnings per Share 2006-2021 | GILD

Gilead Sciences annual and quarterly earnings per share history from 2006 to 2021. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Gilead Sciences EPS for the quarter ending March 31, 2021 was $1.37, a 12.3% increase year-over-year.
  • Gilead Sciences EPS for the twelve months ending March 31, 2021 was $0.25, a 93.59% decline year-over-year.
  • Gilead Sciences 2020 annual EPS was $0.1, a 97.63% decline from 2019.
  • Gilead Sciences 2019 annual EPS was $4.22, a 1.2% increase from 2018.
  • Gilead Sciences 2018 annual EPS was $4.17, a 18.8% increase from 2017.
  
Gilead Sciences Annual EPS
2020 $0.10
2019 $4.22
2018 $4.17
2017 $3.51
2016 $9.94
2015 $11.91
2014 $7.35
2013 $1.81
2012 $1.64
2011 $1.77
2010 $1.66
2009 $1.41
2008 $1.03
2007 $0.82
2006 $-0.65
2005 $0.43
Gilead Sciences Quarterly EPS
2021-03-31 $1.37
2020-12-31 $1.25
2020-09-30 $0.29
2020-06-30 $-2.66
2020-03-31 $1.22
2019-12-31 $2.13
2019-09-30 $-0.92
2019-06-30 $1.47
2019-03-31 $1.54
2018-12-31 $0.01
2018-09-30 $1.60
2018-06-30 $1.39
2018-03-31 $1.17
2017-12-31 $-2.93
2017-09-30 $2.06
2017-06-30 $2.33
2017-03-31 $2.05
2016-12-31 $2.34
2016-09-30 $2.49
2016-06-30 $2.58
2016-03-31 $2.53
2015-12-31 $3.17
2015-09-30 $3.06
2015-06-30 $2.92
2015-03-31 $2.76
2014-12-31 $2.15
2014-09-30 $1.67
2014-06-30 $2.20
2014-03-31 $1.33
2013-12-31 $0.45
2013-09-30 $0.47
2013-06-30 $0.46
2013-03-31 $0.43
2012-12-31 $0.47
2012-09-30 $0.43
2012-06-30 $0.46
2012-03-31 $0.28
2011-12-31 $0.43
2011-09-30 $0.48
2011-06-30 $0.47
2011-03-31 $0.40
2010-12-31 $0.39
2010-09-30 $0.42
2010-06-30 $0.40
2010-03-31 $0.46
2009-12-31 $0.43
2009-09-30 $0.36
2009-06-30 $0.31
2009-03-31 $0.32
2008-12-31 $0.29
2008-09-30 $0.26
2008-06-30 $0.23
2008-03-31 $0.26
2007-12-31 $0.19
2007-09-30 $0.21
2007-06-30 $0.21
2007-03-31 $0.21
2006-12-31 $-0.90
2006-09-30 $-0.03
2006-06-30 $0.14
2006-03-31 $0.14
2005-12-31 $0.15
2005-09-30 $0.10
2005-06-30 $0.10
2005-03-31 $0.09
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $85.648B $24.689B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.815B 10.04
Moderna (MRNA) United States $141.980B 282.88
Amgen (AMGN) United States $138.778B 14.97
CSL (CSLLY) Australia $96.851B 0.00
BioNTech SE (BNTX) Germany $79.303B 57.50
Illumina (ILMN) United States $72.380B 104.37
Regeneron Pharmaceuticals (REGN) United States $61.221B 17.53
Vertex Pharmaceuticals (VRTX) United States $52.182B 20.32
Biogen (BIIB) United States $48.694B 13.37
Genmab (GNMSF) Denmark $29.678B 6.44
Genmab (GMAB) Denmark $29.590B 34.66
BeiGene (BGNE) Cayman Islands $29.247B 0.00
Seagen (SGEN) United States $27.837B 47.05
Horizon Therapeutics Public (HZNP) Ireland $22.481B 28.74
Alnylam Pharmaceuticals (ALNY) United States $21.034B 0.00
Bio-Rad Laboratories (BIO.B) United States $20.768B 44.27
Bio-Techne Corp (TECH) United States $18.755B 98.62
Exact Sciences (EXAS) United States $18.543B 0.00
Incyte (INCY) United States $17.011B 33.63
ARGENX SE-ADR (ARGX) Netherlands $15.619B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $15.484B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.022B 100.96
Zai Lab (ZLAB) China $13.725B 0.00
Repligen (RGEN) United States $13.490B 102.80
Novavax (NVAX) United States $13.287B 0.00
QIAGEN (QGEN) Netherlands $12.035B 20.38
Guardant Health (GH) United States $11.103B 0.00
Intellia Therapeutics (NTLA) United States $9.668B 0.00
CureVac (CVAC) Germany $9.207B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $9.170B 23.68
Mirati Therapeutics (MRTX) United States $8.233B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $8.200B 0.00
Fate Therapeutics (FATE) United States $7.786B 0.00
Acceleron Pharma (XLRN) United States $7.591B 0.00
Ascendis Pharma (ASND) Denmark $6.362B 0.00
Legend Biotech (LEGN) United States $6.224B 0.00
Denali Therapeutics (DNLI) United States $6.184B 221.87
SWEDISH ORP BIO (BIOVF) Sweden $6.024B 21.59
Twist Bioscience (TWST) United States $6.016B 0.00
I-Mab (IMAB) China $6.006B 0.00
Halozyme Therapeutics (HALO) United States $5.885B 32.29
Beam Therapeutics (BEAM) United States $5.757B 0.00
NeoGenomics (NEO) United States $5.436B 922.00
Sarepta Therapeutics (SRPT) United States $5.407B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.387B 0.00
Exelixis (EXEL) United States $5.281B 84.25
Apellis Pharmaceuticals (APLS) United States $5.151B 0.00
Adaptive Biotechnologies (ADPT) United States $5.144B 0.00
Blueprint Medicines (BPMC) United States $5.127B 14.52
Arvinas (ARVN) United States $4.953B 0.00
Vir Biotechnology (VIR) United States $4.636B 0.00
Reata Pharmaceuticals (RETA) United States $4.546B 0.00
SpringWorks Therapeutics (SWTX) United States $4.205B 0.00
Alkermes (ALKS) Ireland $4.174B 123.19
Certara (CERT) United States $4.163B 0.00
AbCellera Biologics (ABCL) $4.110B 0.00
Galapagos (GLPG) Belgium $3.967B 0.00
Arena Pharmaceuticals (ARNA) United States $3.755B 0.00
Emergent Biosolutions (EBS) United States $3.531B 8.54
ACADIA Pharmaceuticals (ACAD) United States $3.465B 0.00
Berkeley Lights (BLI) United States $3.041B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.885B 0.00
Editas Medicine (EDIT) United States $2.839B 0.00
Intra-Cellular Therapies (ITCI) United States $2.788B 0.00
Kymera Therapeutics (KYMR) United States $2.710B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.653B 0.00
Insmed (INSM) United States $2.546B 0.00
Heska (HSKA) United States $2.509B 1094.09
Amicus Therapeutics (FOLD) United States $2.472B 0.00
Vericel (VCEL) United States $2.454B 661.75
Sorrento Therapeutics (SRNE) United States $2.443B 0.00
Myriad Genetics (MYGN) United States $2.437B 0.00
ALX Oncology Holdings (ALXO) United States $2.356B 0.00
Arcus Biosciences (RCUS) United States $2.230B 0.00
Prothena (PRTA) Ireland $2.213B 0.00
Protagonist Therapeutics (PTGX) United States $2.172B 0.00
Cytokinetics (CYTK) United States $2.129B 0.00
Morphic Holding (MORF) United States $2.087B 0.00
Revance Therapeutics (RVNC) United States $2.080B 0.00
Atea Pharmaceuticals (AVIR) United States $2.072B 0.00
Celldex Therapeutics (CLDX) United States $2.033B 0.00
Seer (SEER) $1.959B 0.00
Instil Bio (TIL) United States $1.938B 0.00
Alector (ALEC) United States $1.917B 0.00
Ligand Pharmaceuticals (LGND) United States $1.890B 27.69
Myovant Sciences (MYOV) United Kingdom $1.889B 0.00
C4 Therapeutics (CCCC) United States $1.863B 0.00
MorphoSys AG (MOR) Germany $1.830B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.767B 0.00
Inovio Pharmaceuticals (INO) United States $1.759B 0.00
Castle Biosciences (CSTL) United States $1.750B 0.00
Bluebird Bio (BLUE) United States $1.714B 0.00
Global Blood Therapeutics (GBT) United States $1.702B 0.00
Bionano Genomics (BNGO) United States $1.654B 0.00
Amarin (AMRN) Ireland $1.634B 0.00
PHARMA MAR SA (PHMMF) Spain $1.576B 0.00
NGM Biopharmaceuticals (NGM) United States $1.570B 0.00
Avid Bioservices (CDMO) United States $1.567B 641.25
Harmony Biosciences Holdings (HRMY) United States $1.489B 0.00
Zymeworks (ZYME) Canada $1.482B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.449B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.442B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.440B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.411B 0.00
BioAtla (BCAB) United States $1.380B 0.00
Sangamo Therapeutics (SGMO) United States $1.378B 0.00
REGENXBIO (RGNX) United States $1.374B 0.00
MiMedx (MDXG) United States $1.372B 0.00
PureTech Health (PRTC) United States $1.366B 0.00
Nurix Therapeutics (NRIX) United States $1.366B 0.00
Codexis (CDXS) United States $1.365B 0.00
UniQure (QURE) Netherlands $1.337B 4.55
Ocugen (OCGN) United States $1.330B 0.00
Zealand Pharma (ZEAL) Denmark $1.328B 0.00
Genetron Holdings (GTH) China $1.262B 0.00
Repare Therapeutics (RPTX) Canada $1.236B 0.00
Agenus (AGEN) United States $1.152B 0.00
Precigen (PGEN) United States $1.133B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.084B 0.00
Inhibrx (INBX) United States $1.076B 0.00
Scholar Rock Holding (SRRK) United States $1.075B 0.00
Dynavax Technologies (DVAX) United States $1.070B 0.00
Northwest Biotherapeutics (NWBO) United States $1.045B 0.00
Nkarta (NKTX) United States $1.042B 0.00
Zealand Pharma (ZLDPF) Denmark $1.035B 0.00
MannKind (MNKD) United States $1.022B 0.00
Coherus BioSciences (CHRS) United States $0.989B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.952B 0.00
Shattuck Labs (STTK) United States $0.924B 0.00
Mesoblast (MESO) Australia $0.908B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.906B 28.12
Keros Therapeutics (KROS) United States $0.857B 0.00
Travere Therapeutics (TVTX) United States $0.831B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.824B 0.00
Prometheus Biosciences (RXDX) United States $0.815B 0.00
IDEAYA Biosciences (IDYA) United States $0.806B 0.00
Sutro Biopharma (STRO) United States $0.785B 0.00
RAPT THERAPTICS (RAPT) United States $0.767B 0.00
Mersana Therapeutics (MRSN) United States $0.765B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.761B 0.00
VBI Vaccines (VBIV) United States $0.758B 0.00
G1 THERAPEUTICS (GTHX) United States $0.728B 0.00
Pharming Group (PHAR) Netherlands $0.727B 0.00
Avidity Biosciences (RNA) United States $0.726B 0.00
Pliant Therapeutics (PLRX) United States $0.725B 0.00
Pharming Group (PHGUF) Netherlands $0.720B 23.00
Xenon Pharmaceuticals (XENE) Canada $0.708B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.703B 0.00
Curis (CRIS) United States $0.695B 0.00
Epizyme (EPZM) United States $0.676B 0.00
Adagene (ADAG) China $0.673B 0.00
Merus (MRUS) Netherlands $0.660B 0.00
Affimed (AFMD) Germany $0.654B 0.00
Seres Therapeutics (MCRB) United States $0.651B 0.00
Kadmon Holdings (KDMN) United States $0.647B 0.00
SESEN BIO, INC (SESN) United States $0.646B 0.00
Akoya Biosciences (AKYA) United States $0.644B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
AnaptysBio (ANAB) United States $0.629B 0.00
MeiraGTx Holdings (MGTX) United States $0.620B 0.00
Cara Therapeutics (CARA) United States $0.599B 52.04
ChromaDex (CDXC) United States $0.590B 0.00
Cellectis S.A (CLLS) France $0.589B 0.00
Anika Therapeutics (ANIK) United States $0.578B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.573B 0.00
DBV Technologies S.A (DBVT) France $0.572B 0.00
Precision BioSciences (DTIL) United States $0.567B 0.00
Verastem (VSTM) United States $0.555B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.555B 0.00
ALBIREO PHARMA (ALBO) United States $0.549B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.544B 0.00
AC Immune SA (ACIU) Switzerland $0.529B 0.00
Clene (CLNN) United States $0.528B 0.00
Inventiva S.A (IVA) France $0.519B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.511B 9.32
VistaGen Therapeutics (VTGN) United States $0.509B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.508B 0.00
Clovis Oncology (CLVS) United States $0.505B 0.00
Vaccitech (VACC) United Kingdom $0.500B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.489B 0.00
XBiotech (XBIT) United States $0.486B 0.00
Compugen (CGEN) Israel $0.465B 0.00
Cybin (CLXPF) Canada $0.453B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.426B 0.00
ANI Pharmaceuticals (ANIP) United States $0.420B 11.58
Kindred Biosciences (KIN) United States $0.415B 0.00
Starpharma Holdings (SPHRY) Australia $0.413B 0.00
Athenex (ATNX) United States $0.412B 0.00
Bolt Biotherapeutics (BOLT) United States $0.405B 0.00
Forte Biosciences (FBRX) United States $0.405B 0.00
Spero Therapeutics (SPRO) United States $0.396B 0.00
Oncobiologics (OTLK) United States $0.392B 0.00
Selecta Biosciences (SELB) United States $0.392B 0.00
Geron (GERN) United States $0.389B 0.00
Codiak BioSciences (CDAK) United States $0.381B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.375B 0.00
BeyondSpring (BYSI) United States $0.372B 0.00
BioDelivery Sciences (BDSI) United States $0.370B 15.04
Amryt Pharma (AMYT) United Kingdom $0.370B 0.00
Athersys (ATHX) United States $0.369B 0.00
XOMA (XOMA) United States $0.365B 170.53
Orchard Therapeutics (ORTX) United Kingdom $0.355B 0.00
CytomX Therapeutics (CTMX) United States $0.352B 0.00
AquaBounty Technologies (AQB) United States $0.352B 0.00
Cel-Sci (CVM) United States $0.343B 0.00
SQZ Biotechnologies (SQZ) United States $0.337B 0.00
Gritstone Bio (GRTS) United States $0.329B 0.00
Theratechnologies (THTX) Canada $0.328B 0.00
Cue Biopharma (CUE) United States $0.327B 0.00
UROGEN PHARMA (URGN) United States $0.324B 0.00
Angion Biomedica (ANGN) United States $0.315B 0.00
Puma Biotechnology (PBYI) United States $0.304B 0.00
Fortress Biotech (FBIO) United States $0.303B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.301B 0.00
Neoleukin Therapeutics (NLTX) United States $0.296B 0.00
Opthea (OPT) Australia $0.289B 0.00
Syros Pharmaceuticals (SYRS) United States $0.286B 0.00
Frequency Therapeutics (FREQ) United States $0.285B 0.00
Clearside Biomedical (CLSD) United States $0.283B 0.00
WAVE Life Sciences (WVE) Singapore $0.277B 0.00
IBio (IBIO) United States $0.270B 0.00
Talis Biomedical (TLIS) United States $0.264B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.263B 0.00
Innate Pharma S.A (IPHA) France $0.262B 0.00
Arbutus Biopharma (ABUS) United States $0.259B 0.00
Prima BioMed (IMMP) Australia $0.256B 0.00
Cerecor (CERC) United States $0.254B 0.00
OVID THERAPEUTC (OVID) United States $0.253B 2.49
Paratek Pharmaceuticals (PRTK) United States $0.244B 0.00
Kamada (KMDA) Israel $0.242B 16.48
INmune Bio (INMB) United States $0.241B 0.00
Fulcrum Therapeutics (FULC) United States $0.239B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.236B 0.00
Adicet Bio (ACET) United States $0.235B 0.00
Chiasma (CHMA) United States $0.232B 0.00
Kaleido Biosciences (KLDO) $0.231B 0.00
Cogent Biosciences (COGT) United States $0.230B 0.00
Bellus Health (BLU) Canada $0.227B 0.00
Kala Pharmaceuticals (KALA) United States $0.223B 0.00
Adverum Biotechnologies (ADVM) United States $0.222B 0.00
CorMedix Inc (CRMD) United States $0.221B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.220B 0.00
Trevena (TRVN) United States $0.219B 0.00
TELA Bio (TELA) United States $0.217B 0.00
OSMOTICA PHARM (OSMT) United States $0.208B 0.00
Checkpoint Therapeutics (CKPT) United States $0.208B 0.00
HOOKIPA Pharma (HOOK) United States $0.201B 0.00
Cardiff Oncology (CRDF) United States $0.200B 0.00
ADMA Biologics Inc (ADMA) United States $0.199B 0.00
NextCure (NXTC) United States $0.191B 0.00
Beyond Air (XAIR) United States $0.183B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.178B 0.00
Seelos Therapeutics (SEEL) United States $0.177B 0.00
Biofrontera AG (BFRA) Germany $0.172B 0.00
GENFIT S.A (GNFT) France $0.171B 0.00
Aptinyx (APTX) United States $0.171B 0.00
Nicox SA (NICXF) France $0.171B 0.00
POXEL SA FRANCE (PXXLF) France $0.170B 0.00
Erytech Pharma SA (ERYP) France $0.168B 0.00
VolitionRX (VNRX) United States $0.168B 0.00
Synlogic (SYBX) United States $0.166B 0.00
Strongbridge Biopharma (SBBP) United States $0.162B 0.00
PHASEBIO PHARMA (PHAS) United States $0.160B 0.00
Enzo Biochem (ENZ) United States $0.158B 46.57
VTv Therapeutics (VTVT) United States $0.156B 0.00
Applied Genetic Technologies (AGTC) United States $0.154B 0.00
ObsEva SA (OBSV) Switzerland $0.145B 0.00
Purple Biotech (PPBT) Israel $0.143B 0.00
X4 Pharmaceuticals (XFOR) United States $0.142B 0.00
Antibe Therapeutics (ATBPF) Canada $0.139B 0.00
LogicBio Therapeutics (LOGC) United States $0.134B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.132B 0.00
ABVC BioPharma (ABVC) United States $0.132B 0.00
Viridian Therapeutics (VRDN) United States $0.131B 0.00
Galena Biopharma (SLS) United States $0.129B 0.00
Catalyst Biosciences (CBIO) United States $0.128B 0.00
Eton Pharmaceuticals (ETON) United States $0.126B 0.00
Abeona Therapeutics (ABEO) United States $0.124B 0.00
Entera Bio (ENTX) Israel $0.122B 0.00
Orgenesis (ORGS) United States $0.120B 245.00
Liquidia Technologies (LQDA) United States $0.120B 0.00
Voyager Therapeutics (VYGR) United States $0.119B 3.06
Exicure (XCUR) United States $0.119B 0.00
Cyclerion Therapeutics (CYCN) United States $0.118B 0.00
Palatin Technologies (PTN) United States $0.117B 0.00
Novogen (KZIA) Australia $0.117B 0.00
Cocrystal Pharma (COCP) United States $0.113B 0.00
Eyenovia (EYEN) United States $0.109B 0.00
Longeveron (LGVN) United States $0.109B 0.00
Dyadic (DYAI) United States $0.107B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.105B 0.00
Vascular Biogenics (VBLT) Israel $0.105B 0.00
Pluristem Therapeutics (PSTI) Israel $0.104B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.101B 0.00
Aytu BioPharma (AYTU) United States $0.100B 0.00
Celsion (CLSN) United States $0.096B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.096B 0.00
Yumanity Therapeutics (YMTX) United States $0.093B 0.00
AEterna Zentaris (AEZS) United States $0.088B 0.00
Evofem Biosciences (EVFM) United States $0.088B 0.00
Liminal BioSciences (LMNL) Canada $0.088B 0.00
ARAVIVE, INC (ARAV) United States $0.086B 0.00
Vyant Bio (VYNT) United States $0.086B 0.00
Leap Therapeutics (LPTX) United States $0.085B 0.00
Aptevo Therapeutics (APVO) United States $0.084B 0.00
Zosano Pharma (ZSAN) United States $0.081B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.079B 0.00
AIkido Pharma (AIKI) United States $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
ATyr Pharma (LIFE) United States $0.075B 0.00
Emmaus Life Sciences (EMMA) United States $0.074B 0.00
Evogene (EVGN) Israel $0.074B 0.00
Cidara Therapeutics (CDTX) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.070B 0.00
Protalix BioTherapeutics (PLX) Israel $0.069B 0.00
Cytocom (CBLI) United States $0.067B 0.00
Edesa Biotech (EDSA) Canada $0.066B 0.00
Celyad SA (CYAD) Belgium $0.066B 0.00
DiaMedica Therapeutics (DMAC) United States $0.065B 0.00
Lumos Pharma (LUMO) United States $0.063B 0.00
Alimera Sciences (ALIM) United States $0.061B 0.00
Advaxis (ADXS) United States $0.060B 0.00
TRACON Pharmaceuticals (TCON) United States $0.058B 0.00
Oncotelic Therapeutics (OTLC) United States $0.057B 0.00
ARIDIS PHARMACT (ARDS) United States $0.056B 0.00
BioCardia (BCDA) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.055B 0.00
Cyclo Therapeutics (CYTH) United States $0.053B 0.00
Genetic Technologies (GENE) Australia $0.052B 0.00
Idera Pharmaceuticals (IDRA) United States $0.052B 0.00
Windtree Therapeutics (WINT) United States $0.050B 0.00
Pulmatrix (PULM) United States $0.048B 0.00
AnPac Bio-Medical Science (ANPC) China $0.047B 0.00
Happiness Biotech Group (HAPP) China $0.046B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.046B 0.00
Invo BioScience (INVO) United States $0.045B 0.00
Enveric Biosciences (ENVB) United States $0.041B 0.00
Soligenix (SNGX) United States $0.038B 0.00
Timber Pharmaceuticals (TMBR) United States $0.036B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.86
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
Vallon Pharmaceuticals (VLON) United States $0.031B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
GeoVax Labs (GOVX) United States $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
ThermoGenesis Holdings (THMO) United States $0.028B 0.00
Benitec Biopharma (BNTC) United States $0.027B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.027B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.022B 0.00
ZIVO Bioscience (ZIVO) United States $0.019B 0.00
Palisade Bio (PALI) United States $0.008B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00